Subclassification of Peripheral Dopamine Receptors

References

• Rothballer A. B. The effects of catecholamines in the central nervous system. Pharmacol Rev. 1959; 11: 494–547
   PubMed Web of Science ®Google Scholar
• Fuxe K., Hokfelt T., Bolme P., Goldstein M., Johansson O., Jonsson G., Lidbrink P., Ljungdahl A., Sachs Ch. The topography of central catecholamine pathways in relation to their possible role in blood pressure control. Central Action of Drugs in Blood Pressure Regulation, D. S. Davies, J. L. Reid. Whitefriars, London 1975; 8–23
   Google Scholar
• Bell C., Lang W. J. Neural dopaminergic vasodilator control in the kidney. Nature New Biology 1973; 246: 27–29
   PubMedGoogle Scholar
• Lackovic Z., Neff N. H. Evidence that dopamine is a neurotransmitter in peripheral tissues. Life Sci. 1983; 32: 1665–1674
   PubMed Web of Science ®Google Scholar
• Holtz P., Credner K., Koepp W. Die enzymatische Entstehung von Oxytyramin in Organismus und die physiologische Bedeutung der Dopadecarboxylase. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1942; 200: 356–388
   Google Scholar
• Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972; 24: 1–29
   PubMed Web of Science ®Google Scholar
• Goldberg L. I., Volkman P. H., Kohli J. D. A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol. 1978; 18: 57–59
   PubMed Web of Science ®Google Scholar
• Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature 1979; 277: 93–96
   PubMed Web of Science ®Google Scholar
• Stoff J. C., Kebabian J. W. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1984; 35: 2281–2296
   PubMed Web of Science ®Google Scholar
• Seeman P. Brain dopamine receptors. Pharmacol Rev. 1980; 32: 229–313
   PubMed Web of Science ®Google Scholar
• Spano P. F., Memo M., Stefanini E., Fresia P., Trabucchi M. Detection of multiple receptors for dopamine. Receptors for Neurotransmitters and Peptide Hormones, G. Pepeu, M. J. Kuhar, S. J. Enna. Raven Press, New York 1980; 243–251
   Google Scholar
• Sokoloff P., Martres M. P., Schwartz J. C. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone. Naunyn Schmiedebergs Arch Pharmacol. 1980; 315: 89–102
   PubMed Web of Science ®Google Scholar
• Creese I., Leff S. E. Dopamine receptors: a classification. J Clin Psychopharmacology 1982; 2: 329–335
   PubMed Web of Science ®Google Scholar
• Goldberg L. I., Kohli J. D. Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system?. Multiple Dopamine Receptors, E. Usdin. Comm in Psychopharmacol, 3, Pergamon Press, New York 1979; 447–456
   Google Scholar
• Goldberg L. I., Kohli J. D. Peripheral dopamine receptors: a classification based on potency series and specific antagonism. Trends Pharmacol Sci. 1983; 4: 64–66
   Web of Science ®Google Scholar
• Hilditch A., Drew G. M. Characteristics of the dopamine receptors in the rabbit isolated splenie artery. Eur J Pharmacol. 1981; 72: 287–296
   PubMed Web of Science ®Google Scholar
• Drew G. M., Gower A. J., Hilditch A., Marriott A. S. A pharmacological comparison of dopamine receptors in the cat heart and those mediating emesis. Br J Pharmacol. 1982; 75: 145P
   PubMed Web of Science ®Google Scholar
• Forster C., Drew G. M., Hilditch A., Whalley E. T. Dopamine receptors in human basilar arteries. Eur J Pharmacol. 1983; 87: 227–235
   PubMed Web of Science ®Google Scholar
• Hilditch A., Drew G. M. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog. J Cardiovasc Pharmacol. 1984; 6: 460–469
   PubMed Web of Science ®Google Scholar
• Drew G. M., Hilditch A. Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle. Br J Pharmacol. 1984; 83: 871–881
   PubMed Web of Science ®Google Scholar
• Dallas S., Drew G. M., Hilditch A. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised cat. J Cardiovasc Pharmacol. 1986; 8: 116–125
   PubMed Web of Science ®Google Scholar
• Borison H. L., Wang S. C. Physiology and pharmacology of vomiting. Pharmacol Rev. 1953; 5: 193–230
   PubMed Web of Science ®Google Scholar
• Kohli J. D., Goldberg L. I., Volkman P. H., Cannon J. G. N,N-din-propyl dopamine: a qualitatively different dopamine vascular agonist. J Pharmacol Exp Ther. 1978; 207: 16–22
   PubMed Web of Science ®Google Scholar
• Brown R. A., Hall J. C., Humphries R. G., O'Connor S. E., Smith G. W., Verity A. Peripheral dopamine receptors: agonist potencies in different models. Dopamine Receptor Agonists, A. Carlsson, J. L. G. Nilsson. Acta Pharmaceutica Suecica, 2, Swedish Pharmaceutical Press, Stockholm 1983; 195–197
   Google Scholar
• Marcou M., Munday K. A., Horn N., Woodruff G. N. A study of dopamine receptors in guinea-pig renal tissue. Archs Int Pharmacodyn Ther. 1982; 259: 59–71
   PubMedGoogle Scholar
• Imbs J. L., Schmidt M., Ehrhardt J. D., Schwartz J. The sympathetic nervous system and renal sodium handling: is dopamine involved. J Cardiovasc Pharmacol. 1984; 6: S171–S175
   PubMed Web of Science ®Google Scholar
• Brodde O.-E., Meyer F.-J., Schemuth W., Freistuhler J. Demonstration of specific vascular dopamine receptors mediating vasodilation on the isolated rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol. 1981; 316: 24–30
   PubMed Web of Science ®Google Scholar
• Steinsland O. S., Hieble J. P. Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms. Science 1978; 199: 443–445
   PubMed Web of Science ®Google Scholar
• Dubocovich M. L., Weiner N. Modulation of the stimulationevoked release of 3H-dopamine in the rabbit retina. J Pharmacol Exp Ther. 1980; 212: 144–152
   PubMed Web of Science ®Google Scholar
• Costall B., Lim S. K., Naylor R. J. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity in mice. Eur J Pharmacol. 1981; 73: 175–188
   PubMed Web of Science ®Google Scholar
• Hilditch A., Drew G. M. Peripheral dopamine receptor subtypes -a closer look. Trends Pharmacol Sci. 1985; 6: 396–400
   Web of Science ®Google Scholar